NEW YORK – In cell and gene therapies, the genetic machinery is key to producing the proteins missing or dysregulated in a disease, but whether the therapeutic cassette reaches target cells and how ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

Stem cells are often described as the body's master cells. Healthy stem cells can restore the blood system after cancer ...

In a small study, researchers transplanted stem cells into the brains of 12 Parkinson’s patients, stopping progression and ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to scientists. By engineering human ...

The ability to reprogram cancer cells into stem-like cells using a hydrogel marks a monumental step in cancer research and ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

The answer turned out to be a cutting-edge treatment that few Americans know about, according to Roswell Park Comprehensive ...

With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...